The role of leptin, soluble leptin receptor, adiponectin and visfatin in insulin sensitivity in preterm born children in prepubertal ages

Cytokine

Volumn 64, Issue 1, 2013, Pages 448-453

  Yanni, Diana ^a   Darendeliler, Feyza ^a   Bas, Firdevs ^a   Kucukemre Aydin, Banu ^a   Coban, Asuman ^a   Ince, Zeynep ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Adipocytokine; Adiponectin; Insulin resistance; Leptin; Preterm

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; LEPTIN; LEPTIN RECEPTOR; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROINSULIN;

ADOLESCENT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CATCH UP GROWTH; CHILD; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SMALL FOR DATE INFANT;

ADIPOCYTOKINE; ADIPONECTIN; AGA; APPROPRIATE FOR GESTATIONAL AGE; BMI; BODY MASS INDEX; CATCH UP GROWTH; CUG; ELISA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HDL; HIGH DENSITY LIPOPROTEIN; HOMA-IR; HOMEOSTASIS MODEL ASSESSMENT FOR IR.; IMMUNORADIOMETRIC ASSAY; INSULIN RESISTANCE; IR; IRMA; LEPTIN; PRETERM; SDS; SGA; SMALL FOR GESTATIONAL AGE; SOB-R; SOLUBLE LEPTIN RECEPTOR; STANDARD DEVIATION SCORES;

ADIPONECTIN; BLOOD GLUCOSE; BODY MASS INDEX; CHILD, PRESCHOOL; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PREMATURE BIRTH; PROINSULIN; RECEPTORS, LEPTIN;

EID: 84883557217     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.04.034     Document Type: Article

References (40)

1. Levy-Marchal C., Arslanian S., Cutfield W., et al. ESPE-LWPES-ISPAD-APPES-APEG-SLEP-JSPE. Insulin Resistance in Children Consensus Conference Group. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 2010, 95:5189-5198.
2. Chan J.C., Cheung J.C., Stehouwer C.D., et al. The central roles of obesity-associated dyslipidemia, endothelial activation and cytokines in the metabolic syndrome analysis by structural equation modelling. Int J Obes Relat Metab Disord 2002, 26:994-1008.
3. Meier U., Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004, 50:1511-1525.
4. Bastard J.-P., Maachi M., Lagathu C., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17:4-12.
5. Kratzsch J., Lammert A., Bottner A., et al. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence. J Clin Endocrinol Metab 2002, 87:4587-4594.
6. Jaquet D., Leger J., Tabone M.D., et al. High serum leptin concentrations during catch-up growth of children born with intrauterine growth retardation. J Clin Endocrinol Metab 1999, 84:1949-1953.
7. Weyer C., Funahashi T., Tanaka S. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.
8. Haider D.G., Holzer G., Schaller G., et al. The adipokine visfatin is markedly elevated in obese children. J Pediatr Gastroenterol Nutr 2006, 43:548-549.
9. Sommer G., Garten A., Petzold S., et al. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond) 2008, 115:13-23.
10. Davutoglu M., Ozkaya M., Guler E., et al. Plasma visfatin concentrations in childhood obesity: relationship to insulin resistance and anthropometric indices. Swiss Med Wkly 2009, 139:22-27.
11. Geremia C., Cianfarani S. Insulin sensitivity in children born small for gestational age (SGA). Rev Diabetic Stud 2004, 1:58-65.
12. Rotteveel J., van Weissenbruch M.M., Twisk J.W., et al. Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics 2008, 122:313-321.
13. Soto N., Bazaes R.A., Peña V., et al. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 2003, 88(8):3645-3650.
14. Darendeliler F., Bas F., Bundak R., et al. Insulin resistance and body composition in preterm born children during prepubertal ages. Clin Endocrinol (Oxf) 2008, 68:773-779.
15. Kurtoǧlu S., Hatipoǧlu N., Mazicioǧlu M.M., et al. Body weight, length and head circumference at birth a cohort of Turkish newborns. J Clin Res Pediatr Endocrinol 2012, 4:132-139.
16. Tanner J.M., Whitehouse R.H., Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965: I. Arch Dis Child 1966, 41:454-471.
17. Gökçay G., Furman A., Neyzi O. Updated growth curves for Turkish children aged 15 days to 60 months. Child: Care, Health Develop 2008, 34:454-463.
18. Neyzi O., Furman A., Bundak R., et al. Growth references Turkish children aged 6-18years. Acta Paediatr 2006, 95:1635-1641.
19. Bundak R., Furman A., Gunoz H. Body mass index references for Turkish children. Acta Paediatr 2006, 95:194-198.
20. Hatipoglu N., Mazicioglu M.M., Poyrazoglu S., et al. Waist circumference percentiles among Turkish children under the age of 6years. Eur J Pediatr 2012, 10.1007/s00431-012-1822-5.
21. Ong K.K., Ahmed M.L., Emmett P.M., et al. Association between postnatal catch-up growth and obesity in childhood prospective cohort study. Br Med J 2000, 320:967-971.
22. Sancakli O., Darendeliler F., Bas F., et al. Insulin, adiponectin, IGFBP-1 levels and body composition in small-for-gestational age born non-obese children during prepubertal ages. Clin Endocrinol (Oxf) 2008, 69:88-92.
23. Veening M.A., Van Weissenbruch M.M., Delemarre-Van De Waal H.A. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab 2002, 87:4657-4661.
24. Finken M.J.J., Keijzer-Veen M.G., Dekker F.W., et al. Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia 2006, 49:478-485.
25. Hofman P.L., Regan F., Jackson W.E., et al. Premature birth and later insulin resistance. New Engl J Med 2004, 351:2179-2186.
26. Singhal A., Fewtrell M., Cole T.J., et al. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet 2003, 361(9363):1089-1097.
27. Willemsen R.H., de Kort S.W.K., van der Kaay D.C.M., et al. Independent effects of prematurity on metabolic and cardiovascular risk factors in short small-for-gestational-age children. J Clin Endocrinol Metab 2008, 93:452-458.
28. Willemsen R.H., Leunissen R.W.J., Stijnen T., et al. Prematurity is not associated with reduced insulin sensitivity in adulthood. J Clin Endocrinol Metab 2009, 94:1695-1700.
29. Rotteveel J., van Weissenbruch M.M., Twisk J.W.R., et al. Insulin sensitivity in prematurely born adults: relation to preterm growth restraint. Hormone Res Paediat 2011, 75:252-257.
30. Euser A.M., Finken M.J., Keijzer-Veen M.G., et al. Associations between prenatal and infancy weight gain and BMI, fat mass, and fat distribution in young adulthood: a prospective cohort study in males and females born very preterm. Am J Clin Nutr 2005, 81:480-487.
31. Dulloo A.G., Jacquet J., Seydoux J., et al. The thrifty "catch-up fat" phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. Int J Obesity 2006, 30:523-535.
32. Berndt J., Kloting N., Kralisch S., et al. Plasma visfatin concentration and fat depot-specific mRNA expression in humans. Diabetes 2005, 54:2911-2916.
33. Chang Y.H., Chang D.M., Lin K.C., et al. Visfatin in owerweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabet/Metab Res Rev 2011, 27:515-527.
34. Malamitsi-Puchner A., Briana D.D., Boutsikou M., et al. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007, 119(6):e1314-1318.
35. Siahanidou T., Margeli A., Kappis A., et al. Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein cholesterol levels and dietary long-chain polyunsaturated fatty acids. Metab-Clin Exp 2011, 60:389-393.
36. Choi K.C., Lee S.Y., Yoo H.J., et al. Effect of PPAR-delta agonist on the expression of visfatin, adiponectin, and resistin in rat adipose tissue and 3T3-L1 adipocytes. Biochem Biophys Res Commun 2007, 357:62-67.
37. Retnakaran R., Youn B.S., Liu Y., et al. Correlation of circulating full-length visfatin (PBEF/NAMT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study. Clin Endocrinol (Oxf) 2008, 69:885-893.
38. Giapros V.I., Kiortsis D.N., Evagelidou E.N., et al. Visfatin levels in prepubetal children born small or large for gestational age. Hormone Res Metab 2012, 44:135-139.
39. Von Berghes C., Brabant G., Biebermann H., et al. Pro-insulin and the pro-insulin/insulin ratio in overweight and obese children and adolescents: relation to clinical parameters, insulin resistance, and impaired glucose regulation. Pediat Diab 2011, 12:242-249.
40. Mitanchez-Mokhtari D., Lahlou M., Kieffer F., et al. Both relative insulin resistance and defective islet ß-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. Pediatrics 2004, 113:537-541.